R&D Pipeline

See below an overview of the pipeline in Europe, supporting Jiangsu Hengrui Pharmaceutical’s globalisation strategy:

For an overview of the full company pipeline, follow this link Hengrui Pharmaceuticals.

Pre-clinical
Phase I
Phase II
Phase III
Submission
Marketed Products
1. SHR-1210 Camrelizumab
2. SHR-3162 Fuzuloparib
3. SHR-1904 Claudin 18.2 ADC

Stay Connected

Register to get the latest company news and updates.